Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis

European Journal of Cancer

Volumn 42, Issue 18, 2006, Pages 3274-3286

  Li, Da Qiang ^a   Hou, Yi Feng ^a   Wu, Jiong ^a   Chen, Yi ^b   Lu, Jin Song ^a   Di, Gen Hong ^a   Ou, Zhou Luo ^a   Shen, Zhen Zhou ^a   Ding, Jian ^b   Shao, Zhi Min ^a  

^a Cancer Hospital   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

ALL1 fused gene from chromosome 1q; Breast cancer; Gene expression profile; Metastasis

Indexed keywords

COMPLEMENTARY DNA; GELATINASE A; GELATINASE B; MESSENGER RNA; PROTEIN; RHO FACTOR; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR ETS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST METASTASIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; DNA MICROARRAY; DNA TRANSFECTION; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE AF1Q; PRIORITY JOURNAL; PROTEIN EXPRESSION; UNINDEXED SEQUENCE; UPREGULATION;

BLOOD PROTEINS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MATRIX METALLOPROTEINASES; NEOPLASM METASTASIS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; PROTO-ONCOGENE PROTEIN C-ETS-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHO GTP-BINDING PROTEINS; TRANSFECTION;

EID: 33845305833     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.07.008     Document Type: Article

References (42)

1. Weigelt B., Peterse J.L., and van 't Veer L.J. Breast cancer metastasis: markers and models. Nat Rev Cancer 5 8 (2005) 591-602
2. Muller A., Homey B., Soto H., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 6824 (2001) 50-56
3. Weigelt B., Hu Z., He X., et al. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res 65 20 (2005) 9155-9158
4. Urquidi V., Sloan D., Kawai K., et al. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clin Cancer Res 8 1 (2002) 61-74
5. Lee H., Lin E.C., Liu L., and Smith J.W. Gene expression profiling of tumor xenografts: In vivo analysis of organ-specific metastasis. Int J Cancer 107 4 (2003) 528-534
6. Bandyopadhyay A., Elkahloun A., Baysa S.J., Wang L., and Sun L.Z. Development and gene expression profiling of a metastatic variant of the human breast cancer MDA-MB-435 cells. Cancer Biol Ther 4 2 (2005) 168-174
7. Price J.E. Metastasis from human breast cancer cell lines. Breast Cancer Res Treat 39 1 (1996) 93-102
8. Wang J., Ou Z.L., Hou Y.F., et al. Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential. Oncogene (2006)
9. Ramaswamy S., Ross K.N., Lander E.S., and Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat Genet 33 1 (2003) 49-54
10. Sotiriou C., Neo S.Y., McShane L.M., et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 100 18 (2003) 10393-10398
11. Clark E.A., Golub T.R., Lander E.S., and Hynes R.O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406 6795 (2000) 532-535
12. van 't Veer L.J., Dai H., van de Vijver M.J., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 6871 (2002) 530-536
13. Tse W., Zhu W., Chen H.S., and Cohen A. A novel gene, AF1q, fused to MLL in t(1;11) (q21;q23), is specifically expressed in leukemic and immature hematopoietic cells. Blood 85 3 (1995) 650-656
14. Busson-Le Coniat M., Salomon-Nguyen F., Hillion J., Bernard O.A., and Berger R. MLL-AF1q fusion resulting from t(1;11) in acute leukemia. Leukemia 13 2 (1999) 302-306
15. Lestou V.S., Ludkovski O., Connors J.M., Gascoyne R.D., Lam W.L., and Horsman D.E. Characterization of the recurrent translocation t(1;1)(p36.3;q21.1-2) in non-Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysis. Genes Chromosomes Cancer 36 4 (2003) 375-381
16. Watanabe N., Kobayashi H., Ichiji O., et al. Cryptic insertion and translocation or nondividing leukemic cells disclosed by FISH analysis in infant acute leukemia with discrepant molecular and cytogenetic findings. Leukemia 17 5 (2003) 876-882
17. Jacques C., Baris O., Prunier-Mirebeau D., et al. Two-step differential expression analysis reveals a new set of genes involved in thyroid oncocytic tumors. J Clin Endocrinol Metab 90 4 (2005) 2314-2320
18. Tse W., Meshinchi S., Alonzo T.A., et al. Elevated expression of the AF1q gene, an MLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemia. Blood 104 10 (2004) 3058-3063
19. Keshava C., Whipkey D., and Weston A. Transcriptional signatures of environmentally relevant exposures in normal human mammary epithelial cells: benzo[a]pyrene. Cancer Lett 221 2 (2005) 201-211
20. Xu S.H., Qian L.J., Mou H.Z., et al. Difference of gene expression profiles between esophageal carcinoma and its pericancerous epithelium by gene chip. World J Gastroenterol 9 3 (2003) 417-422
21. Hou Y.F., Yuan S.T., Li H.C., et al. ERbeta exerts multiple stimulative effects on human breast carcinoma cells. Oncogene 23 34 (2004) 5799-5806
22. Li D.Q., Wang L., Fei F., et al. Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry. Proteomics 6 11 (2006) 3352-3368
23. Van Valckenborgh E., Croucher P.I., De Raeve H., et al. Multifunctional role of matrix metalloproteinases in multiple myeloma: a study in the 5T2MM mouse model. Am J Pathol 165 3 (2004) 869-878
24. Zhang L., Fogg D.K., and Waisman D.M. RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells. J Biol Chem 279 3 (2004) 2053-2062
25. Eccles S.A., and Paon L. Breast cancer metastasis: when, where, how?. Lancet 365 9464 (2005) 1006-1007
26. Bittner M., Meltzer P., Chen Y., et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406 6795 (2000) 536-540
27. Welch D.R., Steeg P.S., and Rinker-Schaeffer C.W. Molecular biology of breast cancer metastasis. Genetic regulation of human breast carcinoma metastasis. Breast Cancer Res 2 6 (2000) 408-416
28. Williams T.M., Medina F., Badano I., et al. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem 279 49 (2004) 51630-51646
29. Leeman M.F., Curran S., and Murray G.I. New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J Pathol 201 4 (2003) 528-534
30. Duffy M.J., Maguire T.M., Hill A., McDermott E., and O'Higgins N. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2 4 (2000) 252-527
31. Higashino F., Yoshida K., Noumi T., Seiki M., and Fujinaga K. Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene 10 7 (1995) 1461-1463
32. Saeki H., Kuwano H., Kawaguchi H., Ohno S., and Sugimachi K. Expression of ets-1 transcription factor is correlated with penetrating tumor progression in patients with squamous cell carcinoma of the esophagus. Cancer 89 8 (2000) 1670-1676
33. Ertongur S., Lang S., Mack B., Wosikowski K., Muehlenweg B., and Gires O. Inhibition of the invasion capacity of carcinoma cells by WX-UK1, a novel synthetic inhibitor of the urokinase-type plasminogen activator system. Int J Cancer 110 6 (2004) 815-824
34. Berchem G., Glondu M., Gleizes M., et al. Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis. Oncogene 21 38 (2002) 5951-5955
35. Odero-Marah V.A., Khalkhali-Ellis Z., Chunthapong J., et al. Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells. Cancer Biol Ther 2 4 (2003) 398-403
36. Nobes C.D., and Hall A. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J Cell Biol 144 6 (1999) 1235-1244
37. van Golen K.L., Wu Z.F., Qiao X.T., Bao L.W., and Merajver S.D. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res 60 20 (2000) 5832-5838
38. Kamai T., Tsujii T., Arai K., et al. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 9 7 (2003) 2632-2641
39. Horiuchi A., Imai T., Wang C., et al. Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab Invest 83 6 (2003) 861-870
40. Suwa H., Ohshio G., Imamura T., et al. Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br J Cancer 77 1 (1998) 147-152
41. Folkman J. Endothelial cells and angiogenic growth factors in cancer growth and metastasis. Introduction. Cancer Metastasis Rev 9 3 (1990) 171-174
42. Fahmy R.G., Dass C.R., Sun L.Q., Chesterman C.N., and Khachigian L.M. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat Med 9 8 (2003) 1026-1032